| P2093 | author name string | Gabriele Schoedon | |
| | Esther Bachli | |
| | Tom Skaria | |
| P2860 | cites work | Interleukin-1 in the pathogenesis and treatment of inflammatory diseases | Q24606766 |
| | Pharmacokinetic/pharmacodynamic modeling in inflammation | Q26830621 |
| | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 |
| | NF-kappaB: a key role in inflammatory diseases | Q29617726 |
| | Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression. | Q30422978 |
| | Human Umbilical Vein Endothelial Cells Differ from Other Endothelial Cells in Failing to Express ABO Blood Group Antigens | Q60034609 |
| | Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome | Q71315801 |
| | Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice | Q73587010 |
| | WIF1 prevents Wnt5A mediated LIMK/CFL phosphorylation and adherens junction disruption in human vascular endothelial cells | Q33706544 |
| | IL-4 Causes Hyperpermeability of Vascular Endothelial Cells through Wnt5A Signaling | Q36026778 |
| | NF-kappa B activation as a pathological mechanism of septic shock and inflammation | Q36419091 |
| | Signalling platforms that modulate the inflammatory response: new targets for drug development | Q36611001 |
| | Evolving functions of endothelial cells in inflammation | Q36950913 |
| | Vascular permeability in cardiovascular disease and cancer | Q37129687 |
| | Wnt5A/Ryk signaling critically affects barrier function in human vascular endothelial cells | Q37641124 |
| | Signaling in innate immunity and inflammation | Q37980557 |
| | Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. | Q39246542 |
| | Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules | Q41184705 |
| | TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. | Q44140936 |
| | Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome | Q44762818 |
| | Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. | Q45124656 |
| | Plasma hepatocyte growth factor is increased in early-phase sepsis | Q47436633 |
| | Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond | Q47599422 |
| | Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. | Q47820615 |
| | Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells. | Q48284127 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | Gene Ontology | Q135085 |
| | whole genome sequencing | Q2068526 |
| | vascular endothelium | Q30103326 |
| P304 | page(s) | 414 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Gene Ontology Analysis for Drug Targets of the Whole Genome Transcriptome of Human Vascular Endothelial Cells in Response to Proinflammatory IL-1 | |
| P478 | volume | 10 | |